Lilly's profit doubled in the fourth quarter, driven by its diabetes and obesity treatments Mounjaro and Zepbound, while ...

Lilly expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $58 billion to $61 billion. This story was generated by Automated Insights ( ...

The stock market opened with steep losses Monday in the wake of President Donald Trump’s aggressive new tariffs on Canadian, ...

GM, Ford and Stellantis stock plunged in initial trading Monday in light of a pending trade war. But Wall Street showed some ...

INDIANAPOLIS (WISH ... already accomplished a feat few other single entities have managed: shaking Wall Street, Silicon Valley, and government leaders all at once. “I’ll admit it is ...